Bio Pharma Dive
JANUARY 7, 2022
Amylyx, CinCor and Vigil raised about $480 million combined, a sign of continued investor interest in biotech IPOs. But industry analysts expect fewer and smaller offerings in 2022 due to investor fatigue from high valuations.
World of DTC Marketing
JANUARY 7, 2022
GoodRx promotes itself as a company that allows you to compare drug prices and find coupons at over 60,000 pharmacies across the country, but actually, most pharmacists hate it. When they say compare prescription drug prices, they mean the cost of a prescription if you aren’t using insurance. And advertising? Uh, no. GoodRx makes money in two main ways: Advertisements on their site and a percentage fee every time a GoodRx coupon is used at the pharmacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 7, 2022
Neurimmune, which will license to AstraZeneca an early-stage treatment for a rare form of cardiomyopathy, is probably best known for its invention of the antibody that became Biogen's Alzheimer's drug Aduhelm.
pharmaphorum
JANUARY 7, 2022
AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months. In the latest deal, the pharma group is paying $30 million upfront with another $730 million in milestone’s for global rights to Neurimmune’s NI006, a drug in early-stage clinical for cardiomyopathy, a progressive and fatal complication affecting some patients with ATTR.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
JANUARY 7, 2022
Researchers at the University of Oxford have developed a blood test for the detection of different cancers, and the test can also determine whether a cancer has metastasized. Additionally, the cancer blood test can spot disease in patients that have non-specific symptoms and can help clinicians determine the stage of a cancer. The test is based on the measurement of cancer-associated metabolite biomarkers in the blood using nuclear magnetic resonance (NMR) spectroscopy.
pharmaphorum
JANUARY 7, 2022
Kidney cancer is the 14 th most common cancer, with approximately 400,000 new cases worldwide every year. Renal cell carcinoma (RCC) is by far the most prevalent type of cancer originating from the kidney, making up nine out of ten kidney cancer diagnoses. As chief medical officer, head of global medical affairs, patient safety and patient affairs – putting patient interests first is central to my role and values.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 7, 2022
If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of its longstanding partnership with Exscientia that covers no fewer than 15 programmes.
Scienmag
JANUARY 7, 2022
MINNEAPOLIS / ST. PAUL (01/07/2022) — In a groundbreaking new study, researchers at the University of Minnesota Twin Cities used a customized printer to fully 3D print a flexible organic light-emitting diode (OLED) display. The discovery could result in low-cost OLED displays in the future that could be widely produced using 3D printers by anyone at home, […].
Pharma Times
JANUARY 7, 2022
The platform integrates primary human tissue samples into early target and drug discovery research.
Scienmag
JANUARY 7, 2022
A joint research team led by Profs. LIN Yangting and LIN Honglei from the Institute of Geology and Geophysics of the Chinese Academy of Sciences (IGGCAS) observed water signals in reflectance spectral data from the lunar surface acquired by the Chang’E-5 lander, providing the first evidence of in-situ detection of water on the Moon. Credit: […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
JANUARY 7, 2022
With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.
Scienmag
JANUARY 7, 2022
HOUSTON ? A blood test, combined with a risk model based on an individual’s history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers from The University of Texas MD Anderson Cancer […].
Drug Patent Watch
JANUARY 7, 2022
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 7, 2022
With the long-term goal to realize carbon neutrality, lithium battery has acquired a growingly central role in the development of human society. The accurate yet efficient prognosis on battery state of health (SOH) remains vital in ensuring a safe and reliable operation. In addition, as the demand to increase battery energy density continues to grow, […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Drug Patent Watch
JANUARY 7, 2022
Annual Drug Patent Expirations for ICLUSIG Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three…. The post New patent for Takeda Pharms drug ICLUSIG appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 7, 2022
A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Credit: Vanderbilt University Medical Center A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the […].
XTalks
JANUARY 7, 2022
Pasta is the latest food to receive a better-for-you makeover with the debut of Noodles & Company’s “LEANguini.” The fast-casual pasta chain claims the new noodle has 56 percent fewer net carbs, 30 percent fewer total carbs and 44 percent more protein than traditional wheat noodles, all while maintaining the same taste and appearance as traditional linguine.
Scienmag
JANUARY 7, 2022
Mental time travel — transporting someone from the present through imagining a personal, positive future event — has been proven to help reduce alcohol, tobacco, and drug use. Credit: Virginia Tech Mental time travel — transporting someone from the present through imagining a personal, positive future event — has been proven to help reduce alcohol, […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Tutor
JANUARY 7, 2022
Durian - the King of fruits for health. Manisha Choudhary 1 , Rajesh Vagh 2 , MM Abid Ali Khan 3 , Raaz K. Maheshwari* 4. admin. Sat, 01/08/2022 - 11:09. Tags. Articles.
Scienmag
JANUARY 7, 2022
The research by the Future Sustainable Food Systems research group at the University of Helsinki together with VTT Technical Research Centre of Finland shows that fungus-produced ovalbumin could have the potential to mitigate part of the environmental burden associated with chicken egg white powder. This is especially true when using low carbon energy sources in […].
BioTech 365
JANUARY 7, 2022
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at the 2022 Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at the 2022 … Continue reading →
Scienmag
JANUARY 7, 2022
8 January 2022, Sydney. A team of Australian and international scientists led by Australian Museum (AM) and University of New South Wales (UNSW) palaeontologist Dr Matthew McCurry and Dr Michael Frese of the University of Canberra have discovered and investigated an important new fossil site in New South Wales, Australia, containing superb examples of fossilised […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioTech 365
JANUARY 7, 2022
Immunovant to Present at the 40th Annual J.P. Morgan Healthcare Conference Immunovant to Present at the 40th Annual J.P. Morgan Healthcare Conference NEW YORK, Jan. 07, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc.
Scienmag
JANUARY 7, 2022
Dissolved organic carbon (DOC) is the majority of marine organic carbon. Understanding its source and sink processes is of great significance to global carbon cycle and will provide insights in achieving carbon neutrality. How do different physical and biogeochemical processes interact to contribute to the budgets of DOC and particulate organic carbon (POC)?
BioTech 365
JANUARY 7, 2022
Iovance Biotherapeutics to Present Data on Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® Iovance Biotherapeutics to Present Data on Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy at the 2022 … Continue reading →
Scienmag
JANUARY 7, 2022
Marston leads a multi-institutional team of researchers that was recently awarded a nearly $1.6 million grant by the National Science Foundation to develop new theories of how socio-environment diversity determines the effectiveness, resilience, and adaptability of groundwater self-governance regimes. Their research examines the viability of these regimes under current conditions but also seeks to understand how they […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioTech 365
JANUARY 7, 2022
Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares NEW YORK, … Continue reading →
Scienmag
JANUARY 7, 2022
Led by the University of Bern, an international research team has discovered a sub-Neptune exoplanet orbiting a red dwarf star. The discovery was also made thanks to observations performed by the SAINT-EX observatory in Mexico. SAINT-EX is run by a consortium including the Center for Space and Habitability (CSH) at the University of Bern and […].
BioTech 365
JANUARY 7, 2022
Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc.
Scienmag
JANUARY 7, 2022
WOODS HOLE, Mass. — Stationary marine organisms that don’t ply the ocean, but spend their lives rooted in one spot, have evolved impressive ways to capture prey. The sea anemone Nematostella, for instance, burrows into salt marsh sediments and stays there for life. But it has specialized ‘stinging cells’ that hurl toxins into passing prey, […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
327 
Let's personalize your content